Our commitment to neuroscience
Neuroscience is advancing at an unprecedented rate, and we are proud to be at the forefront of this transformation. Our focus is on helping children and adults suffering from debilitating and degenerative neurological disorders. Our long‐term commitment to advancing neuroscience and toxins research is evidenced by 30 years of clinical experience.
Neuroscience is central to Ipsen’s internal innovation and external partnering, integral to the company’s overall strategy, and a key driver of long‐term value and growth.
Our commitment to patients
Since 1994, Ipsen has focused on pioneering research in neurotoxins. People suffering from neurological disorders need treatments, and we’ve become a global leader in creating them.
We have accomplished this through the research, development, manufacturing and commercialization of neurotoxins to help treat certain types of spasticity in adults and children two years and older. Such disorders include cervical dystonia, cerebral palsy, hemifacial spasm and blepharospasm.
Additionally, our work in neurotoxins extends to aesthetic indications with our partner Galderma, including the reduction of glabellar lines (frown lines).
We also remain focused on bringing medicines to patients where there is high unmet need and we will continue to collaborate where there are opportunities to bring promising new treatments to patients.
A unique educational program
Over 800 experienced physicians benefited from Ipsen’s toxin educational program, the only one in the world with published findings.
Our expertise in neuroscience
Since 1994, Ipsen has focused on pioneering research in neurotoxins. People suffering from neurological disorders need treatments, and we’ve become a global leader in creating them through the research, development, manufacturing and commercialization of neurotoxins to help treat certain types of spasticity in adults and children two years and older, cervical dystonia, cerebral palsy, hemifacial spasm, and blepharospasm. Additionally, our work in neurotoxins extends to aesthetic indications with our partner Galderma, including the reduction of glabellar lines (frown lines).
Ipsen neuroscience clinical trials
We are constantly striving to bring new treatments to the clinical trial stage to meet patients’ unmet medical needs.
Learn moreInvestigator sponsored studies and externally sponsored collaboration
Use of AboBoNT-A/Dysport in:
- Pain
- Neuropathic Pain (e.g., peripheral neuropathy, postherpetic pain, trigeminal pain)
- Orthopedic pain
- Patellofemoral pain syndrome
- Osteoarthritic pain
- Pain (general)
- Depression
- Movement Disorders
- Essential Tremors
- Other movement disorders
- Surgery
- Wound healing
- Pre- / post-operative procedures (e.g., breast surgery)
- Gastroenterology
- Muscle Hypertonia
- Urology
- Cervical Dystonia (motor & non-motor)
- Spasticity*
- MS spasticity
*Aligned with approved indication and life cycle